1. A phase 3, randomized study of ofatumumab combined with bendamustine in rituximab‐refractory iNHL (COMPLEMENT A + B study). (10th May 2021) Authors: Rummel, Mathias J.; Janssens, Ann; MacDonald, David; Keating, Mary‐Margaret; Zaucha, Jan M.; Davis, Jaclyn; Lasher, Janet; Babanrao Pisal, Chaitali; Izquierdo, Miguel; Friedberg, Jonathan W. Journal: British journal of haematology Issue: Volume 193:Number 6(2021) Page Start: 1123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients. (5th June 2018) Authors: Lambertini, Matteo; Campbell, Christine; Bines, José; Korde, Larissa A; Izquierdo, Miguel; Fumagalli, Debora; Del Mastro, Lucia; Ignatiadis, Michail; Pritchard, Kathleen; Wolff, Antonio C; Jackisch, Christian; Lang, Istvan; Untch, Michael; Smith, Ian; Boyle, Frances; Xu, Binghe; Barrios, Carlos H... Journal: Journal of the National Cancer Institute Issue: Volume 111:Number 1(2019) Page Start: 86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. An open‐label, multicenter, efficacy, and safety study of deferasirox in iron‐overloaded patients with non‐transfusion‐dependent thalassemia (THETIS): 5‐year results. Issue 8 (27th May 2022) Authors: Lai, Yong‐Rong; Cappellini, Maria Domenica; Aydinok, Yesim; Porter, John; Karakas, Zeynep; Viprakasit, Vip; Siritanaratkul, Noppadol; Kattamis, Antonis; Liu, Rongrong; Izquierdo, Miguel; Lasher, Janet; Govindaraju, Sameera; Taher, Ali Journal: American journal of hematology Issue: Volume 97:Issue 8(2022) Page Start: E281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cancer cells resist antibody-mediated destruction by neutrophils through activation of the exocyst complex. Issue 6 (21st June 2022) Authors: van Rees, Dieke J; Bouti, Panagiota; Klein, Bart; Verkuijlen, Paul J H; van Houdt, Michel; Schornagel, Karin; Tool, Anton T J; Venet, David; Sotiriou, Christos; El-Abed, Sarra; Izquierdo, Miguel; Guillaume, Sébastien; Saura, Cristina; Di Cosimo, Serena; Huober, Jens; Roylance, Rebecca; Kim, Sung-... Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Crushed deferasirox film‐coated tablets in pediatric patients with transfusional hemosiderosis: Results from a single‐arm, interventional phase 4 study (MIMAS). Issue 8 (31st May 2022) Authors: Wali, Yasser; Hassan, Tamer; Charoenkwan, Pimlak; Trompeter, Sara; Tartaglione, Immacolata; Origa, Raffaella; Gamberini, Maria Rita; Viprakasit, Vip; Izquierdo, Miguel; Opio, Socrates; Roy, Tania; Taher, Ali Journal: American journal of hematology Issue: Volume 97:Issue 8(2022) Page Start: E292 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade. (30th April 2019) Authors: Prat, Aleix; Pascual, Tomás; De Angelis, Carmine; Gutierrez, Carolina; Llombart-Cussac, Antonio; Wang, Tao; Cortés, Javier; Rexer, Brent; Paré, Laia; Forero, Andres; Wolff, Antonio C; Morales, Serafín; Adamo, Barbara; Brasó-Maristany, Fara; Vidal, Maria; Veeraraghavan, Jamunarani; Krop, Ian; Galv... Journal: Journal of the National Cancer Institute Issue: Volume 112:Number 1(2020) Page Start: 46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Long-term outcomes of osilodrostat in Cushing's disease: LINC 3 study extension. Issue 4 (16th September 2022) Authors: Fleseriu, Maria; Newell-Price, John; Pivonello, Rosario; Shimatsu, Akira; Auchus, Richard J; Scaroni, Carla; Belaya, Zhanna; Feelders, Richard A; Vila, Greisa; Houde, Ghislaine; Walia, Rama; Izquierdo, Miguel; Roughton, Michael; Pedroncelli, Alberto M; Biller, Beverly M K Journal: European journal of endocrinology Issue: Volume 187:Issue 4(2022) Page Start: 531 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Long-term outcomes of osilodrostat in Cushing's disease: LINC 3 study extension. Issue 4 (16th September 2022) Authors: Fleseriu, Maria; Newell-Price, John; Pivonello, Rosario; Shimatsu, Akira; Auchus, Richard J; Scaroni, Carla; Belaya, Zhanna; Feelders, Richard A; Vila, Greisa; Houde, Ghislaine; Walia, Rama; Izquierdo, Miguel; Roughton, Michael; Pedroncelli, Alberto M; Biller, Beverly M K Journal: European journal of endocrinology Issue: Volume 187:Issue 4(2022) Page Start: 531 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Phase 1 Study Evaluating Pharmacokinetics and Tolerability of Ofatumumab Combined With Bendamustine in Patients With Indolent B‐Cell Non‐Hodgkin's Lymphoma. Issue 9 (12th July 2022) Authors: Forero‐Torres, Andres; Chandler, Jason Claud; Iyer, Swaminathan P.; Kanate, Abraham S.; Quinlan, Michelle; Hoever, Petra; Izquierdo, Miguel; Davis, Jaclyn; Madan, Sumit Journal: Clinical pharmacology in drug development Issue: Volume 11:Issue 9(2022) Page Start: 1099 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Predictive Role of CD36 Expression in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Trastuzumab. (5th July 2022) Authors: Ligorio, Francesca; Di Cosimo, Serena; Verderio, Paolo; Ciniselli, Chiara Maura; Pizzamiglio, Sara; Castagnoli, Lorenzo; Dugo, Matteo; Galbardi, Barbara; Salgado, Roberto; Loi, Sherene; Michiels, Stefan; Triulzi, Tiziana; Tagliabue, Elda; El-Abed, Sarra; Izquierdo, Miguel; de Azambuja, Evandro; N... Journal: Journal of the National Cancer Institute Issue: Volume 114:Number 12(2022) Page Start: 1720 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗